Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-24

Clinical Trial Update: The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems? [NA]

View source ↗

Summary

A clinical trial investigating memantine as an adjunct to electroconvulsive therapy for major depressive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

Sponsor: Jerrry L Lewis | Conditions: Major Depressive Disorder | NA | Status: WITHDRAWN